Alkermes

This is the limited version of the Alkermes company profile: Join LinkedIn or Sign In to see more information.

Current Company Logo

Fully integrated biotechnology company that develops innovative medicines and drug-delivery technology designed to yield better therapeutic outcomes for patients. The company has two commercial products: RISPERDAL® CONSTA® approved for treatment of schizophrenia and bipolar I disorder, and marketed worldwide through a division of Johnson & Johnson, and VIVITROL® approved for the treatment of alcohol dependence and marketed by Alkermes.

Your Connections to Alkermes

To see how you’re connected: Join Now or Sign In

Popular Profiles at Alkermes

New Hires and Recent Promotions at Alkermes

  • Jim Schoener, Senior Director, Business Development

    was Director, Business Development - last month

  • Cara Kaufhold, Team Leader, Quality Assurance

    was Quality Assurance Senior Associate - last month

  • David Eyerman, Sr. Research Scientist - Neuropharmacology

    was Scientist III - Neuropharmacology - last month

  • Andrew Sorg, Associate Director, Manufacturing

    was Associate Director - 6 months ago

  • Eva Stroynowski, Senior Corporate Communications Specialist

    was Senior Corporate Communications Associate - 2 months ago

To see more new hires & promotions: Join Now or Sign In

Last edited by Divisional Operations Administrative Assistant at AmeriCold Logistics

Key Statistics about Alkermes

Top Locations

Alkermes Headquarters Address
88 Sidney Street
Cambridge, MA 02139-4136
United States
Phone: 617-494-0171
Fax: 617-494-9263
HeadquartersGreater Boston Area
IndustryBiotechnology
TypePublic Company
StatusOperating
Company Size 580 employees
2007 Revenue $240 mil (44%)
Founded1987
Websitehttp://www.alkermes.com
More Alkermes info »
Common Job Titles
Scientist3%
Research Associate3%
Validation Engineer3%
Manufacturing Associate2%
Project Manager2%
Top Schools
Northeastern Univ.3%
Median Age36 years
Gender
Male56%
Female44%
Estimated based on LinkedIn Data

Companies related to Alkermes

Career path for Alkermes employees

before:
after:

See more Related Companies »

Stock Information about Alkermes

In partnership with BusinessWeek

Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.

This LinkedIn Company Profile was created by LinkedIn and is about Alkermes. This page is not endorsed by or affiliated with Alkermes. For questions regarding LinkedIn Company Profiles, contact us.

Alkermes (ALKS) full company profile, stock quotes, financial statements and more.

Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions